CL2019002928A1 - Lipopeptide to potently inhibit HIV, derivative, pharmaceutical composition and use thereof. - Google Patents

Lipopeptide to potently inhibit HIV, derivative, pharmaceutical composition and use thereof.

Info

Publication number
CL2019002928A1
CL2019002928A1 CL2019002928A CL2019002928A CL2019002928A1 CL 2019002928 A1 CL2019002928 A1 CL 2019002928A1 CL 2019002928 A CL2019002928 A CL 2019002928A CL 2019002928 A CL2019002928 A CL 2019002928A CL 2019002928 A1 CL2019002928 A1 CL 2019002928A1
Authority
CL
Chile
Prior art keywords
lipopeptide
derivative
pharmaceutical composition
inhibit hiv
potently inhibit
Prior art date
Application number
CL2019002928A
Other languages
Spanish (es)
Inventor
Yuxian He
Huihui Chong
Yuanmei Zhu
Original Assignee
Shanxi Kangbao Biological Product Co Ltd
Inst Pathogen Biology Cams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Kangbao Biological Product Co Ltd, Inst Pathogen Biology Cams filed Critical Shanxi Kangbao Biological Product Co Ltd
Priority to CL2019002928A priority Critical patent/CL2019002928A1/en
Publication of CL2019002928A1 publication Critical patent/CL2019002928A1/en

Links

CL2019002928A 2019-10-15 2019-10-15 Lipopeptide to potently inhibit HIV, derivative, pharmaceutical composition and use thereof. CL2019002928A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2019002928A CL2019002928A1 (en) 2019-10-15 2019-10-15 Lipopeptide to potently inhibit HIV, derivative, pharmaceutical composition and use thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2019002928A CL2019002928A1 (en) 2019-10-15 2019-10-15 Lipopeptide to potently inhibit HIV, derivative, pharmaceutical composition and use thereof.

Publications (1)

Publication Number Publication Date
CL2019002928A1 true CL2019002928A1 (en) 2020-07-10

Family

ID=71835369

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019002928A CL2019002928A1 (en) 2019-10-15 2019-10-15 Lipopeptide to potently inhibit HIV, derivative, pharmaceutical composition and use thereof.

Country Status (1)

Country Link
CL (1) CL2019002928A1 (en)

Similar Documents

Publication Publication Date Title
DOP2017000137A (en) BENZAMIDES SUBSTITUTED WITH 1,3-THIAZOL-2-ILO.
CL2023001911A1 (en) Glucagon derivative and a composition comprising a long-acting conjugate thereof
NI201700011A (en) 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES.
ECSP19021223A (en) DERIVATIVE OF GLUCAGON, CONJUGATE OF THE SAME, COMPOSITION INCLUDING THE SAME AND THERAPEUTIC USE OF THE SAME
BR112016026291A2 (en) BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
CL2016000698A1 (en) Substituted quinolizine derivatives useful as hiv integrase inhibitors
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
GT201700138A (en) PIRAZOLPIRIDINAMINAS
ECSP17044282A (en) Insulin glargine / lixisenatide fixed ratio formulation
CL2017001904A1 (en) Composition for the treatment of hepatic veno-occlusive disease.
EA201790495A1 (en) PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION
CO2018008450A2 (en) Derivatives of 8-amino-2-oxo-1,3-diaza-spiro- [4.5] -decane
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
ZA201907588B (en) Potent hiv inhibiting lipopeptide, derivative thereof, pharmaceutical composition thereof and use thereof
UY36217A (en) PIRIDONA SUBSTITUTE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
CR20160495A (en) FREE COMPOSITIONS OF CELLS FOR THE RESTORATION OF CELLS AND METHODS FOR THE PREPARATION AND USE OF THE SAME
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
CO2018008626A2 (en) Oritavancin formulations
BR112017024126B8 (en) PHARMACEUTICAL COMPOSITIONS, MICRONIZED COMPOUND A AND/OR AT LEAST ONE MICRONIZED PHARMACEUTICALLY ACCEPTABLE SALT OF COMPOUND A AND USE THEREOF
CL2019002928A1 (en) Lipopeptide to potently inhibit HIV, derivative, pharmaceutical composition and use thereof.
CL2017003465A1 (en) Combined use of bumetanide with valproic acid or one of its pharmaceutically acceptable salts to restore cl-homeostasis and thereby allow the preparation of an effective drug in the treatment of epilepsy, and especially in the treatment of refractory epilepsy.
EA201891848A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF FIBROSIS
AR099405A1 (en) TYPICAL ANTIFUNGICAL COMPOSITION FOR ONICOMYCOSIS TREATMENT
AR104972A1 (en) COMPOSITIONS OF HYDROXIPROPIL b-CYCLODEXTRINE AND METHODS
CL2018001236A1 (en) Pharmaceutical composition containing, as active ingredient, derivative of 7-azaindolin-2-one or pharmaceutically acceptable salt thereof.